Summary The 2015 Magnetic Resonance Imaging in Multiple Sclerosis and 2016
Consortium of Multiple Sclerosis Centres guidelines on the use of MRI in diagnosis and …

Activation of innate immune cells and other compartmentalized inflammatory cells in the
brains and spinal cords of people with relapsing–remitting multiple sclerosis (MS) and …

Blood neurofilament light chain (NfL) is a marker of neuro-axonal injury showing promising
associations with outcomes of interest in several neurological conditions. Although initially …

Longitudinal analysis of white matter lesion changes on serial MRI has become an important
parameter to study diseases with white-matter lesions. Here, we build on earlier work on …

Abstract On average, African Americans with multiple sclerosis demonstrate higher
inflammatory disease activity, faster disability accumulation, greater visual dysfunction, more …

Magnetic resonance imaging (MRI) has developed into the most important tool for the
diagnosis and monitoring of multiple sclerosis (MS). Its high sensitivity for the evaluation of …

Sleep-related disorders have been reported to have a higher prevalence in multiple
sclerosis (MS) than in the general population. They are often undervalued for the presence …

A simple blood-derived biomarker is desirable in the routine management of multiple
sclerosis (MS) patients and serum neurofilament light chain (sNfL) is the most promising …

Multiple sclerosis (MS) is one of the most common neurological disorders in young adults.
The etiology of MS is not known but it is widely accepted that it is autoimmune in nature …

The availability of effective therapies for patients with relapsing-remitting multiple sclerosis
(RRMS) has prompted a re-evaluation of the most appropriate way to measure treatment …